A system for in-vivo cardiac optical mapping.
Dillon
S M
SM
Division of Cardiology, Allegheny University of the Health Sciences, USA.
Kerner
T E
TE
Hoffman
J
J
Menz
V
V
Li
K S
KS
Michele
J J
JJ
D000200:Action Potentials / Q000502:physiology; D000703:Analog-Digital Conversion; D000818:Animals; D001128:Argon; D001794:Blood Pressure / Q000502:physiology; D004285:Dogs; D004554:Electric Countershock; D011211:Electric Power Supplies; D004562:Electrocardiography; D004867:Equipment Design; D005260:Female; D005336:Fiber Optic Technology / Q000295:instrumentation; D005456:Fluorescent Dyes; D006329:Heart Conduction System / Q000503:physiopathology*; D007091:Image Processing, Computer-Assisted / Q000295:instrumentation / Q000379:methods*; D007834:Lasers; D008297:Male; D008564:Membrane Potentials / Q000502:physiology; D009200:Myocardial Contraction / Q000502:physiology; D055095:Optics and Photonics; D010496:Pericardium / Q000503:physiopathology; D011690:Purkinje Fibers / Q000502:physiology; D011726:Pyridinium Compounds; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation; D014693:Ventricular Fibrillation / Q000503:physiopathology* / Q000628:therapy; D014743:Videotape Recording
D005456:Fluorescent Dyes; D011726:Pyridinium Compounds; D001128:Argon; C050019:1-(3-sulfonatopropyl)-4-(beta)(2-(di-n-butylamino)-6-naphthylvinyl)pyridinium betaine